Advertisement

Pathology of the Liver and Gallbladder

  • Robert R. Maronpot
  • David E. Malarkey
Chapter

Abstract

The liver is a major metabolic organ, and the first site of contact of xenobiotics follows oral ingestion or administration. The primary functional unit of the liver is the hepatic lobule. Gradients for metabolizing enzyme and oxygen tension in the hepatic lobule determine toxification and detoxification of ingested xenobiotics with immediately toxic agents causing cell damage in the periphery of the hepatic lobule, while enzymatic generation of toxic metabolites typically affect centrilobular hepatocytes. A wide spectrum of spontaneous degenerative changes occurs in the liver, some changes are age-, species-, and strain-dependent, and the job of the pathologist is to assess the significance of a potential treatment-induced liver changes against the background changes in a particular study. Because the liver has a high regenerative capacity following insult, proliferative changes, including benign and malignant neoplasms, are common, especially in the rodent liver. These proliferative changes also occur with an age-, species-, and strain-related background, and the pathologist must weight any proliferative response against this background incidence. Unique to the liver is a class of proliferative lesions designated as foci of cellular alteration which are localized presumptively preneoplastic responses. Several cell types in addition to hepatocytes are present in the liver, and each needs to be addressed by the pathologist in safety assessment of liver changes. Key to understanding the judgment involved in documenting and categorizing the broad spectrum of liver lesions is the pathology narrative where criteria for assessing hepatopathology is spelled out by the pathologist.

Key words

Hepatic lobule Cell death Apoptosis Fatty change Degeneration Hypertrophy Hyperplasia Foci of cellular alteration Hepatocellular adenoma Hepatocellular carcinoma 

References

  1. Allen DG, Pearse G, Haseman JK, Maronpot RR (2004) Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies. Toxicol Pathol 32:393–401CrossRefGoogle Scholar
  2. Bannasch P, Zerban H (1990) Tumours of the liver. In: Turusov V, Mohr U (eds) Pathology of tumours in laboratory animals, Tumours of the rat, vol 1, 2nd edn. IARC Scientific Publication No 99, pp 199–240Google Scholar
  3. Cattley RC, Popp JA (2002) Liver. In: Haschek WM, Rousseaux CG, Wallig MA (eds) Handbook of toxicologic pathology. Academic Press, San Diego, pp 187–225CrossRefGoogle Scholar
  4. Cattley RC, Popp JA, Vonderfechit SL (2013) Liver, gallbladder and exocrine pancreas. In: Sahota PS, Popp JA, Hardisty JF, Gopinath C (eds) Toxicologic pathology. Nonclinical safety assessment. CRC Press, Boca Raton, pp 314–366Google Scholar
  5. Chatman LA, Morton D, Johnson TO, Anway SD (2009) A strategy for risk management of drug-induced phospholipidosis. Toxicol Pathol 37:997–1005CrossRefGoogle Scholar
  6. Deschl U, Cattrley RC, Harada T et al (2001) Liver, gallbladder, and exocrine pancreas. In: International classification of rodent tumors. The mouse. Springer, Berlin, pp 59–86CrossRefGoogle Scholar
  7. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516CrossRefGoogle Scholar
  8. Elmore SA, Dixon D, Hailey JR, Harada T, Herbert RA, Maronpot RR, Nolte T, Rehg JE, Rittinghausen S, Rosol TJ, Satoh H, Vidal JD, Willard-Mack CL, Creasy DM (2016) Recommendations from the INHAND Apoptosis/Necrosis Working Group. Toxicol Pathol 44:173–188CrossRefGoogle Scholar
  9. Eustis SL, Boorman GA, Harada T, Popp JA (1990) Liver. In: Boorman GA et al (eds) Pathology of the Fischer Rat. Academic Press, San Diego, pp 71–94Google Scholar
  10. Evans JG, Lake BG (1998) The digestive system II. Hepatobiliary system. In: Turton J, Hooson J (eds) Target organ pathology. London, Taylor and Francis, pp 61–98Google Scholar
  11. Foster J (2018) Liver and exocrine pancreas. In: Suttie AW (ed) Boorman’s pathology of the rat. Academic Press, San Diego, pp 81–122CrossRefGoogle Scholar
  12. Frith CH, Ward JM, Turusov VS (1994) Tumours of the liver. In: Turusov V, Mohr U (eds) Pathology of tumours in laboratory animals, Tumours of the mouse, vol 2, 2nd edn. IARC Scientific Publication No 111, pp 223–269Google Scholar
  13. Greaves P (2012) Histopathology of preclinical toxicity studies, 4th edn. Academic Press, Amsterdam, pp 433–536CrossRefGoogle Scholar
  14. Hall AP, Elcombe CR, Foster JR, Harada T, Kaufmann W, Knippel A, Kuttler K, Malarkey DE, Maronpot RR, Nishikawa A, Nolte T, Schulte A, Strauss V, York MJ (2012) Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol 40:971–994CrossRefGoogle Scholar
  15. Halliwell WH (1997) Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol 25:53–60CrossRefGoogle Scholar
  16. Harada T, Maronpot RR, Morris RW, Stitzel KA, Boorman GA (1989) Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol Pathol 17:579–593CrossRefGoogle Scholar
  17. Harada T, Enomoto A, Boorman GA, Maronpot RR (1999) Liver and gallbladder. In: Maronpot RR (ed) Pathology of the mouse. Cache River Press, Vienna, IL, pp 119–126Google Scholar
  18. Haschek EM, Rousseaux CG, Wallig MA (2010) Fundamentals of toxicologic pathology, 2nd edn. Academic Press, Amsterdam, pp 197–236CrossRefGoogle Scholar
  19. Hoenerhoff MJ, Hong HH, Ton TV, Lahousse SA, Sills RC (2009) A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer. Toxicol Pathol 37:835–848CrossRefGoogle Scholar
  20. Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, Auerbach SS, Gerrish K, Bushel PR, Shockley KR, Peddada SD, Sills RC (2011) Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer. Toxicol Pathol 39:678–699CrossRefGoogle Scholar
  21. Kim Y, Sills RC, Houle CD (2005) Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Toxicol Pathol 33:175–180CrossRefGoogle Scholar
  22. Lipman RD, Gaillard ET, Harrison DE, Bronson RT (1993) Husbandry factors and the prevalence of age-related amyloidosis in mice. Lab Anim Sci 43:439–444PubMedGoogle Scholar
  23. Malarkey DE, Devereux TR, Dinse GE, Mann PC, Maronpot RR (1995) Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis 16:2617–2625CrossRefGoogle Scholar
  24. Malarkey DE, Johnson K, Ryan L, Boorman G, Maronpot RR (2005) New insights into functional aspects of liver morphology. Toxicol Pathol 33:27–34CrossRefGoogle Scholar
  25. Maronpot RR, Haseman JK, Boorman GA, Eustis SE, Rao GN, Huff JE (1987) Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position. Arch Toxicol Suppl 10:10–26CrossRefGoogle Scholar
  26. Maronpot RR, Harada T, Murthy AS, Boorman GA (1989) Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: current practices of the National Toxicology Program. Toxicol Pathol 17:675–683; discussion 683–4CrossRefGoogle Scholar
  27. Maronpot RR, Yoshizawa K, Nyska A, Harada T, Flake G, Mueller G, Singh B, Ward JM (2010) Hepatic enzyme induction: histopathology. Toxicol Pathol 38:776–795CrossRefGoogle Scholar
  28. Maronpot RR, Nyska A, Foreman JE, Ramot Y (2016) The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms). Crit Rev Toxicol 46:641–675CrossRefGoogle Scholar
  29. Morton D, Kemp RK, Francke-Carroll S, Jensen K, McCartney J, Monticello TM, Perry R, Pulido O, Roome N, Schafer K, Sellers R, Snyder PW (2006) Best practices for reporting pathology interpretations within GLP toxicology studies. Toxicol Pathol 34:806–809CrossRefGoogle Scholar
  30. Newsholme SJ, Fish CJ (1994) Morphology and incidence of hepatic foci of cellular alteration in Sprague-Dawley rats. Toxicol Pathol 22(5):524–527CrossRefGoogle Scholar
  31. NNLA. National Toxicology Program Nonneoplastic Lesion Atlas. Hepatobiliary System (2019). https://ntp.niehs.nih.gov/nnl/hepatobiliary/index.htm
  32. Teutsch HF, Schuerfeld D, Groezinger E (1999) Three-dimensional reconstruction of parenchymal units in the liver of the rat. Hepatology 29:494–505CrossRefGoogle Scholar
  33. Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, Malarkey DE, Kaufmann W, Kuttler K, Deschl U, Nakae D, Gregson R, Vinlove MP, Brix AE, Singh B, Belpoggi F, Ward JM (2010) Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38:5S–81SCrossRefGoogle Scholar
  34. Tsuda H, Fukushima S, Wanibuchi H, Morimura K, Nakae D, Imaida K, Tatematsu M, Hirose M, Wakabayashi K, Moore MA (2003) Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol Pathol 31:80–86PubMedGoogle Scholar
  35. Turusov VS, Deringer MK, Dunn TB, Stewart HL (1973) Malignant mouse-liver tumors resembling human hepatoblastomas. J Natl Cancer Inst 51:1689–1695CrossRefGoogle Scholar
  36. Turusov VS, Torii M, Sills RC, Willson GA, Herbert RA, Hailey JR, Haseman JK, Boorman GA (2002) Hepatoblastomas in mice in the US National Toxicology Program (NTP) studies. Toxicol Pathol 30:580–591CrossRefGoogle Scholar
  37. Wiedmeyer CE (2018) Evaluation of hepatic function and injury. In: Kurtz DM, Travlos GS (eds) The clinical chemistry of laboratory animals, 3rd edn. CRC Press, Boca Raton, pp 367–406Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Robert R. Maronpot
    • 1
  • David E. Malarkey
    • 2
  1. 1.Maronpot Consulting LLCRaleighUSA
  2. 2.National Toxicology Program, National Institutes of Environmental ScienceResearch Triangle ParkUSA

Personalised recommendations